Home›Companies›Healthcare›Restora Medical

Restora Medical, Inc.

Develops an investigational nerve stimulation device for people with sleep apnea.

Updated Nov 10, 2026·Latest SEC filing Jun 18, 2026·Suggest an edit

About Restora Medical

Restora Medical is a private company based in Irvine, California, incorporated in 2023 in Delaware. It has reported $21,024,999 raised in three offerings on Form D since January 2024. Its chief executive is Quan Ni.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 18, 2026May 29, 2026amended Jun 18, 2026$11,500,000of $15.0M target5$2.3MEquityRule 506(b)Form D/A ↗1 earlier filing
Feb 19, 2025Mar 6, 2025amended Jun 18, 2026$6,024,999of $12.0M target11$547KEquityRule 506(b)Form D/A ↗1 earlier filing
Jan 8, 2024Jan 23, 2024amended Jun 18, 2026$3,500,000of $7.4M target4$875KEquity, DebtRule 506(b)Form D/A ↗1 earlier filing
Total, three offerings$21,024,999

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Restora Medical's Form D filed Jun 18, 2026.

YZ
Ye Zhang
Director
Also a director and promoter at Cyanhill USD.
LW
Lixiao Wang
Director
CK
Chau Khuong
Director
QN
Quan Ni
Founder and CEO, director

Sources

  1. SECRestora Medical, Inc. Form D, filed May 29, 2026
  2. SECRestora Medical, Inc. Form D, filed Mar 6, 2025
  3. SECRestora Medical, Inc. Form D, filed Jan 23, 2024
  4. SECRestora Medical, Inc. filing history
  5. ResearchUniversity of Utah: Quan Ni